The Panadol-to-Sensodyne supplier’s pricing power and structural growth opportunity remain mispriced
Haleon (HLN) 390.9p Market cap: £35.6 billion Geopolitical turbulence and Donald Trump’s tariffs mean uncertainties abound for investors, with the outlook for global markets and economies likely to remain unclear for some time to come. Given this backdrop, savvy portfolio builders should increase their exposure to high-quality, cash-generative large-caps whose earnings have a defensive bent. One shining example is Haleon (HLN) , the world-leading consumer health company with a...